Ads
related to: treatment for acute leukemia- ALL Treatment Option
Component of Multi-Agent
Chemotherapy for ALL
- Ordering Guide
View HCP Resources and
Download Ordering Guide
- About Treatment
Learn About a Potential
ALL Treatment Option.
- Clinical Data
View Safety &
Clinical Data Profile.
- AYA Treatment Guidelines
View Clinical Outcomes In
Adolescent & Young Adult Patients
- Patient Support
Learn More About
Patient Assistance Options.
- ALL Treatment Option
Search results
Results From The WOW.Com Content Network
Acute myelogenous leukemia (AML) occurs far more commonly in adults than in children, and more commonly in men than women. It is treated with chemotherapy. The five-year survival rate is 20%. [19] Subtypes of AML include acute promyelocytic leukemia, acute myeloblastic leukemia, and acute megakaryoblastic leukemia.
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. [1] Symptoms may include feeling tired, pale skin color, fever , easy bleeding or bruising, enlarged lymph nodes , or bone pain. [ 1 ]
Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original diagnosis of leukemia. In most cases, these can be classified according to the lineage, myeloid or lymphoid , of the malignant cells that grow uncontrolled, but some are mixed and for those such an assignment is not possible.
A syndrome similar to disseminated intravascular coagulation can develop during the initial few days of treatment or at the time the leukemia is diagnosed, and treatment can be complicated by a differentiation syndrome characterised by fever, fluid overload and low oxygen levels. [63] Acute promyelocytic leukemia is considered curable. [64]
Revumenib, sold under the brand name Revuforj, is an anti-cancer medication used for the treatment of acute leukemias harboring lysine methyltransferase 2A gene (KMT2A) rearrangements. [1] It is designed to disrupt the interaction between menin and KMT2A (also known as MLL), which plays a role in the pathogenesis of these leukemias. [ 2 ]
Acute myeloid leukemia, excluding acute promyelocytic leukemia: DAT: daunorubicin, cytarabine (ara-C), tioguanine: Acute myeloid leukemia: DCEP dexamethasone, cyclophosphamide, etoposide, platinum agent: relapsed or refractory multiple myeloma DHAP: dexamethasone (a steroid hormone), cytarabine (ara-C), platinum agent: Non-Hodgkin lymphomas ...
Ads
related to: treatment for acute leukemia